Secukinumab M22161
The add to cart button will appear once you select the values above
Specifications
| inquiry |
CAS Number:
875356-43-7
Target:
IL Receptor
Molecular formula:
——
Formula weight:
151 kDa
Purity:
>98% (HPLC)
Stability:
≥ 2 years
Product description:
Secukinumab is a fully humanized monoclonal anti-IL-17A antibody and the first in its class to be approved by the US Food and Drug Administration for the treatment of moderate to severe plaque psoriasis.
Note:
Research use only, not for human use.
More info:
Email info@sobekbio.com
Orders:
Email orders@sobekbio.com